Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
76.52
+3.68 (5.05%)
At close: Dec 20, 2024, 4:00 PM
76.15
-0.37 (-0.48%)
After-hours: Dec 20, 2024, 6:06 PM EST
PRAX Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for PRAX stock have an average target of 146.33, with a low estimate of 48 and a high estimate of 270. The average target predicts an increase of 91.23% from the current stock price of 76.52.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +56.82% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +56.82% | Nov 7, 2024 |
| Needham | Needham | Strong Buy Reiterates $151 | Strong Buy | Reiterates | $151 | +97.33% | Nov 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $143 → $163 | Buy | Maintains | $143 → $163 | +113.02% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +56.82% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
1.49M
from 2.45M
Decreased by -39.19%
Revenue Next Year
966.96K
from 1.49M
Decreased by -35.02%
EPS This Year
-10.31
from -18.69
EPS Next Year
-11.57
from -10.31
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.2M | 3.2M | 77.0M | |||
| Avg | 1.5M | 966,960 | 32.6M | |||
| Low | 1.1M | n/a | 844,760 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -9.9% | 111.7% | 7,859.5% | |||
| Avg | -39.2% | -35.0% | 3,273.8% | |||
| Low | -56.4% | - | -12.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -10.23 | -9.12 | -6.94 | |||
| Avg | -10.31 | -11.57 | -11.42 | |||
| Low | -10.17 | -14.57 | -18.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.